Expert overview on the recent developments in mantle cell lymphoma

New dexamethasone combination yields two-fold improvement in median PFS in multiple myeloma

ASCO 2015: Latest developments in multiple myeloma

ASCO 2015: Latest in chronic lymphocytic leukaemia

Dasatinib plus intensive chemo versus stem cell transplant for Philadelphia chromosome positive ALL

Improved care has extended lifespan of childhood cancer survivors since the 1970s

Improved care has extended lifespan of childhood cancer survivors since the 1970s

New targeted treatments for blood cancers: Multiple myeloma, non-Hodgkin lymphoma, genomic marker mismatch repair and myelofibrosis

Targeted drug daratumumab shows promise in heavily treatment-resistant multiple myeloma

Ibrutinib combination regimen shows substantial benefits in relapsed CLL

Novel JAK inhibitor pacritinib proves effective for easing symptoms of myelofibrosis

New ibrutinib combination regimen shows substantial benefits in relapsed chronic lymphocytic leukaemia